Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
AMPH - Amphastar Pharmaceuticals, Inc.
Market Cap 2.98B P/E 35.45 EPS this Y 9.00% Ern Qtrly Grth 6.60%
Income 137.54M Forward P/E 18.87 EPS next Y 19.30% 50D Avg Chg 15.00%
Sales 644.4M PEG 0.50 EPS past 5Y 66.53% 200D Avg Chg 61.00%
Dividend N/A Price/Book 5.42 EPS next 5Y 22.60% 52W High Chg -3.00%
Recommedations 2.20 Quick Ratio 1.65 Shares Outstanding 48.87M 52W Low Chg 131.00%
Insider Own 22.02% ROA 11.07% Shares Float 37.47M Beta 0.84
Inst Own 70.56% ROE 23.55% Shares Shorted/Prior 3.87M/3.60M Price 61.69
Gross Margin 54.91% Profit Margin 21.35% Avg. Volume 438,853 Target Price 63.25
Oper. Margin 30.31% Earnings Date May 7 Volume 258,200 Change 1.73%
Healthcare | Drug Manufacturers - Specialty & Generic | United States
About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals, Inc. News
04/12/24 Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth
04/04/24 Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know
04/01/24 Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/27/24 Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
04:50 PM Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
03/20/24 Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
03/11/24 Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
03/08/24 Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares
03/06/24 Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares
03/06/24 Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
03/02/24 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript
02/29/24 Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call
02/28/24 Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
02/28/24 Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance
02/28/24 Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
02/22/24 Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know
02/22/24 Wall Street Bulls Look Optimistic About Amphastar (AMPH): Should You Buy?
02/21/24 Amphastar (AMPH) to Report Q4 Earnings: What's in the Cards?
02/20/24 Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
02/16/24 It May Be Time To Revisit Amphastar Once It Settles After A Plunge
AMPH Chatroom

User Image Nosh Posted - 5 days ago

$AMPH Will be adding again on Monday.

User Image EquityInvest Posted - 1 week ago

$AMPH strike 45 puts expire tomorrow! Nicely in the money :)

User Image tea_dubz Posted - 1 week ago

$AMPH bought some May calls here

User Image Chaomane Posted - 1 week ago

$AMPH finally oversold on the weekly rsi for the first time since covid lows

User Image Nizmeister Posted - 1 week ago

$XERS Gvoke 4,681 -2.5% $LLY $AMPH Baqsimi 5,851 -11.9% Yikes for Baqsimi. Gvoke 80% now.

User Image Villidj_Idjit Posted - 2 weeks ago

$AMPH Chinese water torture, these little candles going down, down, down, drip, drip, drip.

User Image Bugislaus Posted - 2 weeks ago

$AMPH Double top and broke the trendline. How low will this go? All the way down to 200SMA?

User Image EquityInvest Posted - 2 weeks ago

$AMPH below 40 keep falling bitch!!!

User Image NeoTrinity Posted - 2 weeks ago

$AMPH Here you'll find presentation from the company today. the outlook is looking positive to me. https://ir.amphastar.com/websites/amphastar/English/1/home.html

User Image EquityInvest Posted - 2 weeks ago

$AMPH sell before they speak you know it will be bad!!!!

User Image griffygriff3 Posted - 3 weeks ago

@Dr_Stoxx Why is $AMPH still dropping? When will it start going up? Thank you.

User Image insiderbuyingselling Posted - 3 weeks ago

$AMPH new insider selling: 500 shares. http://insiderbuyingselling.com/?t=AMPH

User Image Stock_Titan Posted - 3 weeks ago

$AMPH Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/AMPH/amphastar-pharmaceuticals-to-present-at-the-23rd-annual-needham-1bs4ndszym8m.html

User Image griffygriff3 Posted - 03/31/24

$AMPH Let’s have a great April!

User Image Nosh Posted - 1 month ago

$AMPH Added 36%...at $43.71.

User Image Villidj_Idjit Posted - 1 month ago

The middle 2 lines on the $AMPH chart are what technical analysts call a (support and/or resistance) zone.

User Image griffygriff3 Posted - 1 month ago

$AMPH 🖕

User Image EquityInvest Posted - 1 month ago

$AMPH https://stocks.apple.com/A8YpZMUxoS5mIYDtMx5lJDw SHORT!!!!!

User Image RockitMann Posted - 1 month ago

$AMPH Company has consistent revenue growth, clean balance sheet and positive cash flow, yet has sold off visciously despite good earnings. What gives?

User Image griffygriff3 Posted - 1 month ago

$AMPH Ideally we’ll be close to 60 by early May, and a great earnings report around May 9 would then propel us to new highs.

User Image griffygriff3 Posted - 1 month ago

$AMPH It appears we need to flush a few large turds down to the sewer, then we can start tracking North.

User Image CubicleTrader24 Posted - 1 month ago

$AMPH Consolidating in the box. Which way will we break?

User Image insiderbuyingselling Posted - 1 month ago

$AMPH new insider selling: 12500 shares. http://insiderbuyingselling.com/?t=AMPH

User Image Stock_Titan Posted - 1 month ago

$AMPH Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference https://www.stocktitan.net/news/AMPH/amphastar-pharmaceuticals-to-present-at-the-barclays-26th-annual-wr0a817qdat0.html

User Image insiderbuyingselling Posted - 1 month ago

$AMPH new insider selling: 500 shares. http://insiderbuyingselling.com/?t=AMPH

User Image BornKing Posted - 1 month ago

$AMPH $52 open Tuesday 🤷🏾

User Image griffygriff3 Posted - 1 month ago

$AMPH Did y’all watch the last 10 minutes of trading during regular session on Friday? There was a starving bull (or whale) absolutely demolishing the asking shares, which is why Im feeling very bullish heading into the new week.

User Image BornKing Posted - 1 month ago

$AMPH 😩🤣dummies

User Image Zcasperg Posted - 1 month ago

$AMPH looks like a good spot to hop on with a few, been watching awhile, I like this company…overreaction yesterday is my gain I guess.

User Image TD_ Posted - 1 month ago

$XERS from X: @BiotechAnalysst latest week of data reflects the impact of the shortened #holiday week $XERS Gvoke 4,512 +0.7% $AMPH Baqsimi 6,051 -10.5%

Analyst Ratings
Needham Hold Apr 10, 24
JP Morgan Overweight Mar 5, 24
B of A Securities Neutral Nov 17, 23
Wells Fargo Equal-Weight May 17, 23
Piper Sandler Overweight Oct 25, 22
Capital One Overweight Jul 29, 22
Wells Fargo Equal-Weight Mar 15, 22
Piper Sandler Overweight Mar 11, 22
Piper Sandler Overweight Jan 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Petersen Floyd F. Director Director Feb 01 Sell 53.35 500 26,675 80,333 02/02/24
Luo Mary Z. COO,Chief Scientist.. COO,Chief Scientist & Chairman Jan 08 Sell 59.35 219,800 13,045,130 1,235,802 01/10/24
Petersen Floyd F. Director Director Jan 02 Sell 61.13 500 30,565 80,833 01/03/24
Zhou Rong Senior EVP, Producti.. Senior EVP, Production Center Dec 01 Sell 59.08 7,830 462,596 112,420 12/05/23
Zhou Rong Senior EVP, Producti.. Senior EVP, Production Center Dec 01 Option 15.3 7,830 119,799 115,934 12/05/23
Petersen Floyd F. Director Director Dec 01 Sell 57.69 500 28,845 81,333 12/04/23
PRINS RICHARD K Director Director Nov 17 Sell 55.86 4,000 223,440 31,895 11/20/23
PRINS RICHARD K Director Director Nov 13 Sell 52.50 5,000 262,500 35,895 11/15/23
Petersen Floyd F. Director Director Nov 01 Sell 45.3021 500 22,651 81,833 11/02/23
Petersen Floyd F. Director Director Oct 02 Sell 45.7791 500 22,890 82,333 10/03/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Aug 28 Sell 53.13 28,816 1,530,994 69,669 08/29/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Aug 28 Option 16.74 28,816 482,380 98,485 08/29/23
ZASLOFF MICHAEL A Director Director Aug 15 Sell 57.2165 12,759 730,025 33,826 08/16/23
PRINS RICHARD K Director Director Aug 15 Sell 57.3892 4,163 238,911 42,895 08/16/23
Zhou Rong EVP, Production Cent.. EVP, Production Center Jun 20 Option 11.33 9,651 109,346 112,341 06/21/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer May 18 Sell 44.35 10,500 465,675 105,148 05/22/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer May 18 Option 13.35 10,500 140,175 115,648 05/22/23
Zhou Rong EVP, Production Cent.. EVP, Production Center May 18 Sell 44.21 10,000 442,100 87,598 05/19/23
Zhou Rong EVP, Production Cent.. EVP, Production Center May 18 Option 14.4 10,000 144,000 97,598 05/19/23
Deflin Gayle Director Director May 18 Sell 44.0116 4,519 198,888 4,163 05/19/23
Petersen Floyd F. Director Director May 17 Sell 43.1310 5,000 215,655 80,117 05/18/23
ZASLOFF MICHAEL A Director Director May 15 Sell 42.178 7,500 316,335 43,869 05/16/23
PRINS RICHARD K Director Director May 12 Sell 42.78 10,000 427,800 44,342 05/16/23
PRINS RICHARD K Director Director May 12 Option 16.69 10,000 166,900 49,342 05/16/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 17 Option 13.35 5,632 75,187 110,780 04/18/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 17 Sell 42.35 5,632 238,515 105,148 04/18/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Apr 13 Sell 41.5 11,494 477,001 69,215 04/14/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Apr 13 Option 20.23 11,494 232,524 80,709 04/14/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 13 Sell 42.35 4,868 206,160 105,148 04/14/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 13 Option 13.35 4,868 64,988 110,016 04/14/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Apr 10 Sell 40 5,000 200,000 69,215 04/12/23
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Apr 10 Option 20.23 5,000 101,150 74,215 04/12/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 10 Sell 40.35 10,032 404,791 105,148 04/12/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Apr 10 Option 13.35 10,032 133,927 115,180 04/12/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Mar 15 Sell 36.43 12,776 465,430 118,451 03/17/23
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Mar 15 Option 14.95 6,688 99,986 131,227 03/17/23
Petersen Floyd F. Director Director Mar 01 Sell 35.85 500 17,925 85,608 03/02/23
Petersen Floyd F. Director Director Nov 01 Sell 31.1306 500 15,565 87,608 11/02/22
Petersen Floyd F. Director Director Sep 01 Sell 29.443 500 14,722 88,608 09/02/22
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Aug 09 Option 13.35 10,000 133,500 110,480 08/10/22
PETERS WILLIAM J CFO, EVP & Treasurer CFO, EVP & Treasurer Aug 09 Sell 38.35 10,000 383,500 100,480 08/10/22
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Aug 08 Option 19.79 8,055 159,408 64,662 08/10/22
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Aug 08 Sell 38.5 8,055 310,118 61,607 08/10/22
Petersen Floyd F. Director Director Aug 01 Sell 37.477 500 18,738 89,108 08/02/22
Gerst Diane G. Director Director Jul 18 Option 20.08 1,520 30,522 14,362 07/19/22
Gerst Diane G. Director Director Jul 18 Sell 37.23 1,520 56,590 12,842 07/19/22
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Jul 15 Option 19.79 10,837 214,464 72,444 07/18/22
Liawatidewi Yakob EVP Corp Admin Cente.. EVP Corp Admin Center Jul 15 Sell 36.46 10,837 395,117 61,607 07/18/22
Gerst Diane G. Director Director Jul 11 Option 20.08 1,521 30,542 14,363 07/12/22
Gerst Diane G. Director Director Jul 11 Sell 36.26 1,521 55,151 12,842 07/12/22